Brunhilde Felding‐Habermann

7.3k total citations · 1 hit paper
43 papers, 5.4k citations indexed

About

Brunhilde Felding‐Habermann is a scholar working on Molecular Biology, Immunology and Allergy and Oncology. According to data from OpenAlex, Brunhilde Felding‐Habermann has authored 43 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Immunology and Allergy and 12 papers in Oncology. Recurrent topics in Brunhilde Felding‐Habermann's work include Cell Adhesion Molecules Research (18 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Platelet Disorders and Treatments (9 papers). Brunhilde Felding‐Habermann is often cited by papers focused on Cell Adhesion Molecules Research (18 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Platelet Disorders and Treatments (9 papers). Brunhilde Felding‐Habermann collaborates with scholars based in United States, Germany and Canada. Brunhilde Felding‐Habermann's co-authors include Mihaela Lorger, Emilia Fransvea, Zaverio M. Ruggeri, Alan Saven, Ján Pilch, Barbara M. Mueller, Timothy E. O’Toole, John R. Yates, Emily I. Chen and Johannes A. Hewel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Brunhilde Felding‐Habermann

42 papers receiving 5.4k citations

Hit Papers

Contribution of platelets to tumour metastasis 2011 2026 2016 2021 2011 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Contribution of platelets to tumour metastasis
    2011 1.3k citations Brunhilde Felding‐Habermann et al. Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brunhilde Felding‐Habermann United States 28 2.4k 2.0k 1.1k 1.0k 821 43 5.4k
Anne E. Cress United States 41 2.8k 1.2× 1.8k 0.9× 931 0.8× 1.4k 1.4× 924 1.1× 147 5.4k
Catherine Butterfield United States 22 3.8k 1.6× 1.4k 0.7× 1.8k 1.6× 611 0.6× 731 0.9× 33 6.5k
Giulia Taraboletti Italy 47 4.0k 1.7× 2.1k 1.1× 2.2k 2.0× 1.1k 1.0× 506 0.6× 112 7.1k
Andrew P. Mazar United States 53 3.5k 1.5× 2.3k 1.2× 3.0k 2.8× 1.3k 1.3× 884 1.1× 176 7.8k
Curzio Rüegg Switzerland 45 3.0k 1.2× 2.2k 1.1× 1.3k 1.2× 1.0k 1.0× 598 0.7× 132 6.4k
M. OʼReilly United States 14 3.7k 1.6× 1.9k 1.0× 2.2k 2.0× 662 0.6× 741 0.9× 30 6.0k
Achim Krüger Germany 45 2.6k 1.1× 2.1k 1.1× 2.2k 2.0× 631 0.6× 355 0.4× 111 5.8k
Pnina Brodt Canada 46 3.2k 1.4× 2.5k 1.3× 2.2k 2.0× 876 0.8× 689 0.8× 115 6.8k
Jack Henkin United States 42 2.5k 1.1× 1.3k 0.6× 2.1k 1.9× 485 0.5× 532 0.6× 111 4.8k
Jasti S. Rao United States 54 4.4k 1.8× 2.4k 1.2× 3.8k 3.4× 1.2k 1.2× 500 0.6× 169 8.3k

Countries citing papers authored by Brunhilde Felding‐Habermann

Since Specialization
Citations

This map shows the geographic impact of Brunhilde Felding‐Habermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brunhilde Felding‐Habermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brunhilde Felding‐Habermann more than expected).

Fields of papers citing papers by Brunhilde Felding‐Habermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brunhilde Felding‐Habermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brunhilde Felding‐Habermann. The network helps show where Brunhilde Felding‐Habermann may publish in the future.

Co-authorship network of co-authors of Brunhilde Felding‐Habermann

This figure shows the co-authorship network connecting the top 25 collaborators of Brunhilde Felding‐Habermann. A scholar is included among the top collaborators of Brunhilde Felding‐Habermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brunhilde Felding‐Habermann. Brunhilde Felding‐Habermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kularatne, Sumith A., Jennifer Ma, Virginie Tardif, et al.. (2014). A CXCR4‐Targeted Site‐Specific Antibody–Drug Conjugate. Angewandte Chemie. 126(44). 12057–12061. 4 indexed citations
2.
Kularatne, Sumith A., V. Deshmukh, Jennifer Ma, et al.. (2014). A CXCR4‐Targeted Site‐Specific Antibody–Drug Conjugate. Angewandte Chemie International Edition. 53(44). 11863–11867. 57 indexed citations
3.
Hutchins, Benjamin M., Stephanie A. Kazane, Karin Staflin, et al.. (2011). Site-Specific Coupling and Sterically Controlled Formation of Multimeric Antibody Fab Fragments with Unnatural Amino Acids. Journal of Molecular Biology. 406(4). 595–603. 58 indexed citations
4.
Felding‐Habermann, Brunhilde, et al.. (2011). Contribution of platelets to tumour metastasis. Nature reviews. Cancer. 11(2). 123–134. 1321 indexed citations breakdown →
5.
Hutchins, Benjamin M., Stephanie A. Kazane, Karin Staflin, et al.. (2011). Selective Formation of Covalent Protein Heterodimers with an Unnatural Amino Acid. Chemistry & Biology. 18(3). 299–303. 45 indexed citations
6.
Staflin, Karin, Joseph S. Krueger, Jane Forsyth, et al.. (2010). Targeting activated integrin αvβ3 with patient-derived antibodies impacts late-stage multiorgan metastasis. Clinical & Experimental Metastasis. 27(4). 217–231. 11 indexed citations
7.
Jain, Shashank, Masahiko Zuka, Susan Russell, et al.. (2007). Platelet glycoprotein Ibα supports experimental lung metastasis. Proceedings of the National Academy of Sciences. 104(21). 9024–9028. 154 indexed citations
8.
Liu, Ying, Sebastian C.J. Steiniger, Young Soo Kim, et al.. (2007). Mechanistic Studies of a Peptidic GRP78 Ligand for Cancer Cell-Specific Drug Delivery. Molecular Pharmaceutics. 4(3). 435–447. 102 indexed citations
9.
Kim, Young Soo, Antonietta M. Lillo, Sebastian C.J. Steiniger, et al.. (2006). Targeting Heat Shock Proteins on Cancer Cells:  Selection, Characterization, and Cell-Penetrating Properties of a Peptidic GRP78 Ligand. Biochemistry. 45(31). 9434–9444. 150 indexed citations
10.
Felding‐Habermann, Brunhilde, Richard A. Lerner, Antonietta M. Lillo, et al.. (2004). Combinatorial antibody libraries from cancer patients yield ligand-mimetic Arg-Gly-Asp-containing immunoglobulins that inhibit breast cancer metastasis. Proceedings of the National Academy of Sciences. 101(49). 17210–17215. 30 indexed citations
11.
Rolli, Melanie, Emilia Fransvea, Ján Pilch, Alan Saven, & Brunhilde Felding‐Habermann. (2003). Activated integrin αvβ3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proceedings of the National Academy of Sciences. 100(16). 9482–9487. 262 indexed citations
12.
Kunicki, Thomas J., Douglas S. Annis, & Brunhilde Felding‐Habermann. (1997). Molecular Determinants of Arg-Gly-Asp Ligand Specificity for β3 Integrins. Journal of Biological Chemistry. 272(7). 4103–4107. 19 indexed citations
13.
Lanza, Paola, Brunhilde Felding‐Habermann, Zaverio M. Ruggeri, Maurizio Zanetti, & Rosario Billetta. (1997). Selective Interaction of a Conformationally-constrained Arg-Gly- Asp (RGD) Motif with the Integrin Receptor αvβ3 Expressed on Human Tumor Cells. Blood Cells Molecules and Diseases. 23(2). 230–241. 16 indexed citations
14.
Felding‐Habermann, Brunhilde, Steve Silletti, Fang Mei, et al.. (1997). A Single Immunoglobulin-like Domain of the Human Neural Cell Adhesion Molecule L1 Supports Adhesion by Multiple Vascular and Platelet Integrins. The Journal of Cell Biology. 139(6). 1567–1581. 109 indexed citations
15.
Felding‐Habermann, Brunhilde, Rolf Habermann, Enrique Saldı́var, & Zaverio M. Ruggeri. (1996). Role of β3 Integrins in Melanoma Cell Adhesion to Activated Platelets under Flow. Journal of Biological Chemistry. 271(10). 5892–5900. 143 indexed citations
16.
Barbour, Suzanne E., et al.. (1992). Glycolipid depletion using a ceramide analogue (PDMP) alters growth, adhesion, and membrane lipid organization in human A431 cells. Journal of Cellular Physiology. 150(3). 610–619. 52 indexed citations
17.
Felding‐Habermann, Brunhilde, Bruce A. Fenderson, Linda Park, et al.. (1990). A ceramide analog inhibits T cell proliferative response through inhibition of glycosphingolipid synthesis and enhancement of N,N-dimethylsphingosine synthesis. Biochemistry. 29(26). 6314–6322. 83 indexed citations
18.
Felding‐Habermann, Brunhilde, et al.. (1988). Melanoma-associated gangliosides in the fish genus Xiphophorus.. PubMed. 48(12). 3454–60. 10 indexed citations
19.
Jennemann, Richard, Brunhilde Felding‐Habermann, Rudolf Geyer, Stephan Stirm, & Herbert Wiegandt. (1987). Carbohydrate analysis of chicken heart glycolipids. Archives of Biochemistry and Biophysics. 258(1). 240–247. 6 indexed citations
20.
Felding‐Habermann, Brunhilde, Richard Jennemann, Jürgen Schmitt, & Herbert Wiegandt. (1986). Glycosphingolipid biosynthesis in early chick embryos. European Journal of Biochemistry. 160(3). 651–658. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne E. Cress Breakdown of academic impact, for papers by Catherine Butterfield Breakdown of academic impact, for papers by Giulia Taraboletti Breakdown of academic impact, for papers by Andrew P. Mazar Breakdown of academic impact, for papers by Curzio Rüegg Breakdown of academic impact, for papers by M. OʼReilly Breakdown of academic impact, for papers by Achim Krüger Breakdown of academic impact, for papers by Pnina Brodt Breakdown of academic impact, for papers by Jack Henkin Breakdown of academic impact, for papers by Jasti S. Rao
Rankless by CCL
2026